期刊文献+

阿尔茨海默病PET/SPECT受体显像的临床研究进展 被引量:1

The clinical progress of PET/SPECT receptor imaging of Alzheimer' s disease
原文传递
导出
摘要 本文综述以阿尔茨海默病(Alzheimer's disease,AD)为代表的痴呆疾病的中枢神经系统乙酰胆碱、苯二氮卓类、5-羟色胺、多巴胺及组胺等递质的受体及受体亚型水平的PET/SPECT显像的临床研究进展,揭示PET/SPECT受体显像在AD的病因、病理机制、早期诊断以及药物评价等研究方面的作用,并且对该领域的研究方向提供一些建议。 Many PET/SPECT investigations have demonstrated that there are abnormities in some transmitter and receptor systems in the CNS of Alzheimer's Disease, such as acetylcholine, benzodiazepine, 5-serotonin, dopamine and histamine, etc.. Here,we introduce these progression and development directions in respect of clinical PET/SPECT studies, which may be useful in the studies of AD's etiology, pathology, early diagnosis and drug evaluation.
出处 《中华神经医学杂志》 CAS CSCD 2003年第6期465-467,共3页 Chinese Journal of Neuromedicine
关键词 阿尔茨海默病 PET SPECT 受体 AD 痴呆 中枢神经系统 Alzheimer's disease PET SPECT receptor
  • 相关文献

参考文献10

  • 1Masashi Ohyama,Michio Senda,Kiichi Ishiwata,Shin Kitamura,Masahiro Mishina,Kenji Ishii,Hinako Toyama,Keiichi Oda,Yasuo Katayama.Preserved benzodiazepine receptors in Alzheimer’s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF[J].Annals of Nuclear Medicine.1999(5)
  • 2Tsuyoshi Yoshida,Yasuo Kuwabara,Yuichi Ichiya,Masayuki Sasaki,Toshimitsu Fukumura,Atsushi Ichimiya,Masashi Takita,Koji Ogomori,Kouji Masuda.Cerebral muscarinic acetylcholinergic receptor measurement in Alzheimer’s disease patients on11C-N-methyl-4-piperidyl benzilate — Comparison with cerebral blood flow and cerebral glucose metabolism—[J].Annals of Nuclear Medicine.1998(1)
  • 3Wiebke Sihver,Agneta Nordberg,Bengt Langstrom,et al.Development of ligands for in vivo imaging of cerebral nicotinic receptors[].Behavioural Brain Research.2000
  • 4Marutle A,Warpman U,Bognanovic N,et al.Neuronal nicotinic receptor deficits in Alzheimer patients with the swedish amyloid precursor 670/671 mutation[].Journal of Neurochemistry.1999
  • 5Annachiara Cagnin,David J Brooks,Angus M Kennedy,et al.Invivo measurement of activated microglia in dementia[].The Lancet.2001
  • 6J Versijpt,KJ Van Laere,F Dumont,et al.Imaging of the 5-HT(2A)system:age-,gender-,and Alzheimer’s disease-related findings[].Neurobiology of Aging.2003
  • 7Kemppainen,N,Ruottinen,H,Nagren,K,et al.PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD[].Neurology.2000
  • 8Rinne JO,Sahlberg N,Ruottinen H,et al.Striatal Uptake of the Dopamine Reuptake Ligand11C-?-CFTis Reduced in Alzhei mer’s Disease Assessed by Positron Emission Tomography[].Neurology.1998
  • 9M Higuchi,K Yanai,N Okamura,et al.Histamine H1 receptors in patients with Alzheimer’s disease assessed by positron emission tomography[].Neuropsychopharmacology.2000
  • 10Brown,D. R.,Wyper,D. J.,Owens,J.123Iodo-MK-801: a spect agent for imaging the pattern and extent of glutamate (NMDA) receptor activation in Alzheimer’s disease[].J Psychiatr Res.1997

同被引文献81

引证文献1

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部